Climb Bio (CLYM) Total Non-Current Liabilities (2020 - 2024)

Climb Bio (CLYM) has 5 years of Total Non-Current Liabilities data on file, last reported at $5.3 million in Q4 2024.

• Quarterly Total Non-Current Liabilities rose 86.31% year-over-year to $5.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.3 million (up 86.31% YoY) and the FY2024 annual result came in at $5.3 million, up 86.31% from the prior year.
• Total Non-Current Liabilities rose to $5.3 million in Q4 2024, from $3.4 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $7.9 million in Q2 2022 to a low of $2.5 million in Q4 2020.
• A 5-year average of $4.8 million and a median of $4.4 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2021 — Total Non-Current Liabilities jumped 140.09% — and 2023, when it plunged 54.63%.
• Tracing CLYM's Total Non-Current Liabilities over 5 years: stood at $2.5 million in 2020, then surged by 140.09% to $6.0 million in 2021, then climbed by 4.08% to $6.3 million in 2022, then sank by 54.63% to $2.8 million in 2023, then surged by 86.31% to $5.3 million in 2024.
• The last three Total Non-Current Liabilities figures came in at $5.3 million (Q4 2024), $3.4 million (Q3 2024), and $3.7 million (Q2 2024), per Business Quant data.